Introduction
Myelin basic protein (MBP)' is, in most mammalian species, the major antigen responsible for experimental allergic encepha-lomyelitis (EAE), an autoimmune disease which serves as a model for the human demyelinating disease multiple sclerosis (MS). In several rodent models, EAE is mediated by a T cell response to MBP, as demonstrated by the ability of MBP-reactive T cells derived from spleen and lymph nodes of an immunized donor to adoptively transfer disease into naive syngeneic recipients (1) (2) (3) (4) . In humans, MBP-reactive T cells are thought to play a role in acute disseminated encephalomyelitis that follows infection or vaccination (5, 6) and have long been suspected as effector cells in MS (7) . MBP-reactive T cells are present in the circulation of patients with MS but are also present in healthy individuals (8) (9) (10) (11) (12) . The role of these circulating T cell populations in the induction of human MS is unknown. Cross-species adoptive transfer experiments have been attempted with human donor cells transferred into rodent hosts, but have been unsuccessful (N. Joshi, unpublished observations) or have yielded uncertain results (13) (14) (15) .
The common marmoset Callithrixjacchus (C. jacchus) represents a unique species for the study of T cell-mediated diseases in primates, because these monkeys are born as naturally occurring bone marrow chimeras. While the individual animals arise from separate ova that are fertilized independently, the placentas of the developing animals fuse, resulting in a crosscirculation of bone marrow-derived elements between the fetuses. Thus, while the animals are genetically distinct, they share, and are tolerant to, each other's bone marrow-derived cell populations (16) . The natural chimerism in C. jacchus theoretically makes possible adoptive transfer of functional T cell populations between members of an outbred species without initiating an alloresponse. We have recently found that a relapsing-remitting form of EAE which bears a strong clinical and pathological resemblance to human MS can be induced in C. jacchus by immunization with human CNS white matter.2 Immunized animals display specific proliferative responses to MBP, suggesting that MBP is an autoantigen in C. jacchus EAE. Thus, this outbred species of non-human primate is characterized by bone marrow chimerism and susceptibility to CNS disease, creating an opportunity to elucidate the antigenic repertoire and the encephalitogenic potential of circulating populations of MBP-reactive T cells.
Here we show that MBP-reactive T cell clones can be derived from the circulation of unimmunized, healthy C. jacchus. Furthermore, these T cell clones are consistently able to induce an inflammatory CNS disease by adoptive transfer. Different T cell clones derived from the same animal and reactive against different epitopes of MBP appear to be equally encephalitogenic. The data are the first direct demonstration that T cells reactive against a self-antigen and present in the normal circulating pool are capable of mediating an autoimmune disease.
Methods
Animals. C. jacchus marmosets were maintained in primate colonies at the University of California, San Francisco and New England Regional Primate Research Center. The animals used in this study were cared for in accordance with the guidelines of the Committee on Animals of the Harvard Medical School and those of the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council. A maximum of 2.5 ml of blood every other week was taken from each animal. CSF was obtained by puncture of the cisterna magna. Phlebotomy, cisternal puncture, and intravenous transfer of T cells were done under brief anesthesia (Ketamine, 10 mg i.m.). Magnetic resonance imaging (MRI) was performed under anesthesia with Propofol, 20-50 mg/h in intravenous drip.
Production and characterization of T cell clones. MBP-reactive T cell clones were derived from PBMC of naive (e.g., unimmunized) C. jacchus by limiting dilution. Freshly isolated PBMC were cultured at 105 cells/well in 96 round-bottom well plates (Corning Inc., Corning, NY) with purified human MBP (50 pg/ml final concentration) (17) in RPMI 1640 supplemented with 2 mM glutamine (Gibco, Grand Island, NY), 20 mM Hepes buffer and 10% controlled processed serum replacement-2 (CPSR-2) (Sigma Chemical Co., St. Louis, MO), and penicillin/ streptomycin/gentamycin at standard concentrations (Gibco). After 3 d the culture medium was supplemented with 10% heat-inactivated human AB serum (Pel-Freez Biologicals, Rogers, AR), 10% human T cell growth factor (Cellular Prods. Inc., Buffalo, NY), 40 U/ml recombinant IL-2 (Hazelton Systems, Inc., Aberdeen, MD) and 4 U/mI IL-4 (Genzyme Corp., Cambridge, MA) and this growth medium was changed every 3 d for 9 d. T cells were restimulated at the end of the cycle by addition of 105 syngeneic and/or chimeric freshly isolated PBMC pulsed with MBP (50 Htg/ml) and irradiated (3000 rad) as APC.
T cell clones were expanded by multiple cycles of restimulation with MBP/APC followed by culture in growth medium. After 4-6 cycles, MBP-reactive clones were identified and characterized for peptide specificity by [3H] Adoptive transfer. At the end of the stimulation cycle 107 T cells were rested for 48 h in CPSR-2 medium, then restimulated with either: MBP (50 4g/ml) in the presence of irradiated (3000 rad) syngeneic/ chimeric PBMC as APC; or 4 og/ml concanavalin A. Control, MBP nonreactive clones were restimulated with 4 jsg/ml concanavalin A.
Growth medium was added after 48 h, and 24 h later cells were harvested, washed with RPMI, resuspended in 2 ml of 0.9% saline i.v. and injected into the popliteal vein, followed immediately by intravenous injection of 100 killed Bordetella pertussis organisms. 48 h later, a second intravenous injection of Bordetella pertussis was administered. In an additional control group, two animals received the two injections of Bordetella pertussis but no cells. Table II ).
Assessment ofEAE. The appearance of EAE was monitored in recipient animals by daily clinical evaluation, examination of CSF, MRI, and neuropathologic criteria. The severity of disease was graded by two independent observers blinded as to the identity of the clone transferred: 0, normal; 1, lethargy, anorexia, weight loss; 2, ataxia and either paraparesis/monoparesis, sensory loss or brain stem syndrome including gaze palsy, blindness or dysarthria; 3, paraplegia or hemiplegia; 4, quadriplegia. Postmortem examination was performed on formalin-fixed tissues.
Results
Adoptive transfer of EAE by natural MBP-reactive T cell clones. We first demonstrated that APC from chimeric siblings were equivalent to syngeneic APC in the presentation of MBP or the relevant peptide to the T cell clones derived from one member of the sets (Table I) . Therefore, selected clones could be adoptively transferred into the animal of origin or into a chimeric sibling. (Table II) . Sequential CSF analyses performed in two animals (chimeric set 3) indicated that pleocytosis preceded the onset of neurologic signs (Fig. 1) . In the same two animals, MRI studies were performed after the onset of the neurologic signs. Foci of in- creased signal intensity on T2-weighted images were present, suggestive of edema ( Fig. 2A) . On Ti-weighted images, obtained following administration of contrast material, areas of gadolinium enhancement appeared in CNS white matter, indicative of blood brain barrier breakdown (Fig. 2, B EAE. CSF studies performed at day 14 and 28 after transfer were normal (Table II) . Postmortem examination of the cerebrum and the spinal cord was performed in three animals with EAE and in one control animal. The animals with EAE were killed between day 20 and day 22 after adoptive transfer of T cell clones, corresponding to 6-9 d after the onset of the clinical signs (Table II) . At this stage of disease, occasional areas of necrosis and inflammation were present in two of the diseased animals (Table II, Fig. 2D ), but foci of demyelination and gliosis were notably absent. No lesion was observed in the control animal studied.
Antigenic repertoire of natural encephalitogenic T cell clones. The frequency of MBP-reactive T cell clones in circulat- ing PBMC of normal C. jacchus ranged between 3 and 7 per lo-, similar to the frequency estimated to be present in the circulation of healthy humans (8) (9) (10) (11) (12) . Mapping of the antigenic peptides recognized by individual clones indicated that multiple regions of the MBP molecule were recognized by naturally occurring T cells (Fig. 3) . The pattern of reactivity to overlapping peptides identified differences in the fine specificity between clones reactive against similar regions of MBP, further increasing the number of epitopes recognized. For (Fig. 3) . Similarly, encephalitogenicity in the blood-derived T cell clones was not restricted by recognition of a single antigenic region of MBP. Four clones, each reactive against one of three different fragments of the molecule (aa 11-30, 143-162, and 153-172), could efficiently transfer disease (Table II) . In chimeric set 1, two different clones derived from the same animal, reactive respectively against the amino terminus and carboxyl terminus regions of MBP, were encephalitogenic. These data indicate diversity in the T cell response to MBP that may result in clinical disease.
Discussion
MBP-reactive T cells could readily be cloned from the peripheral blood of normal unimmunized C. jacchus primates. They were similar in several respects to the repertoire of circulating MBP-reactive cells described in human blood (8) (9) (10) (11) (12) . First, circulating MBP-reactive T cells occur at similar frequencies in the two species. Second, fine specificity mapping of different T cell clones derived from single individuals indicated diversity of recognition to multiple different epitopes of MBP. Thus, both in C. jacchus and human primate PBMC, a high fiequency of MBP-reactive T cells and diversity in MBP epitope recognition are characteristic.
The bone marrow chimerism in C. jacchus made possible the direct demonstration that MBP-reactive T cells were encephalitogenic following expansion and adoptive transfer. Thus, potential disease-inducing populations of MBP-reactive T cells are normally present in primates. In rats, Schluesener and Wekerle were able to isolate a single encephalitogenic MBP-reactive T cell line from lymph node of the EAE susceptible Lewis strain, but a similar line derived from the resistant BN strain was nonencephalitogenic (19) . The Lewis line was successfully derived only after multiple negative attempts, and following negative selection of autologous MHC-reactive T cells. This was the first demonstration that EAE-inducing populations are present in the normal immune system. The current data demonstrate that these cells are in relative abundance in the circulation of normal outbred primates and are diverse in terms of their recognition of different epitopes of MBP. In C. jacchus, MBP- reactive T cells are neither deleted, nor irreversibly tolerized, in the peripheral pool.
What mechanisms prevent development of spontaneous EAE in C. jacchus? MBP-reactive T cells must first penetrate the blood-brain barrier to mediate disease, a process that is influenced by activation (20) . Activation by specific antigen, a relevant superantigen (21) (25) .
Mapping data in C. jacchus are in agreement with a previous report suggesting that the carboxy terminus of MBP contains antigenic determinants in primates (26) but also indicates that the natural encephalitogenic repertoire in C. jacchus is broad. In most inbred rodents examined, only exceedingly restricted populations of T cells mediate acute EAE. For example, the encephalitogenic response to MBP is largely directed against the 1-9 amino terminus in the H-2U mouse, against several epitopes within the 89-101 fragment in H-2S mouse, and against the 68-88 fragment in the Lewis rat (27) (28) (29) . Similar to C. jacchus, diversity in recognition of MBP peptides appears to be characteristic of healthy humans and also patients with multiple sclerosis (MS) (8, 9, 12, (30) (31) (32) (33) 
